tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
RemeGen’s Telitacicept Gains Approval for Myasthenia Gravis Treatment in China
PremiumCompany AnnouncementsRemeGen’s Telitacicept Gains Approval for Myasthenia Gravis Treatment in China
2M ago
RemeGen Co., Ltd. Announces 2024 AGM with Key Resolutions
Premium
Company Announcements
RemeGen Co., Ltd. Announces 2024 AGM with Key Resolutions
2M ago
RemeGen Co., Ltd. Announces Strategic Governance Changes at 2025 Shareholder Meeting
Premium
Company Announcements
RemeGen Co., Ltd. Announces Strategic Governance Changes at 2025 Shareholder Meeting
2M ago
RemeGen Co., Ltd. Strengthens Governance with New Audit Committee
PremiumCompany AnnouncementsRemeGen Co., Ltd. Strengthens Governance with New Audit Committee
2M ago
RemeGen Co., Ltd. Enhances Corporate Governance with New Nomination Committee
Premium
Company Announcements
RemeGen Co., Ltd. Enhances Corporate Governance with New Nomination Committee
2M ago
RemeGen Co., Ltd. Announces New H Shares Placement to Raise HK$806 Million
Premium
Company Announcements
RemeGen Co., Ltd. Announces New H Shares Placement to Raise HK$806 Million
3M ago
RemeGen Co., Ltd. Announces Board Composition and Leadership Roles
PremiumCompany AnnouncementsRemeGen Co., Ltd. Announces Board Composition and Leadership Roles
4M ago
RemeGen Co., Ltd. Reports Strong 2024 Revenue Growth and Pipeline Advancements
Premium
Company Announcements
RemeGen Co., Ltd. Reports Strong 2024 Revenue Growth and Pipeline Advancements
4M ago
RemeGen’s Telitacicept Study Gains Spotlight at 2025 AAN Meeting
Premium
Company Announcements
RemeGen’s Telitacicept Study Gains Spotlight at 2025 AAN Meeting
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100